These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15113085)

  • 21. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update.
    Lapolla A; Fedele D; Seraglia R; Traldi P
    Mass Spectrom Rev; 2006; 25(5):775-97. PubMed ID: 16625652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of glycation sites in proteins by high-resolution mass spectrometry combined with isotopic labeling.
    Stefanowicz P; Kijewska M; Kluczyk A; Szewczuk Z
    Anal Biochem; 2010 May; 400(2):237-43. PubMed ID: 20156417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycation of a lysine-containing tetrapeptide by D-glucose and D-fructose--influence of different reaction conditions on the formation of Amadori/Heyns products.
    Jakas A; Katić A; Bionda N; Horvat S
    Carbohydr Res; 2008 Sep; 343(14):2475-80. PubMed ID: 18656854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on N-terminal glycation of peptides in hypoallergenic infant formulas: quantification of alpha-N-(2-furoylmethyl) amino acids.
    Penndorf I; Biedermann D; Maurer SV; Henle T
    J Agric Food Chem; 2007 Feb; 55(3):723-7. PubMed ID: 17263466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation pathways and opioid activity data for 3-hydroxypyridinium compounds derived from glucuronic acid and opioid peptides by Maillard processes.
    Horvat S; Roscić M; Lemieux C; Nguyen TM; Schiller PW
    Chem Biol Drug Des; 2007 Jul; 70(1):30-9. PubMed ID: 17630992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".
    Richter T; Münch G; Lüth HJ; Arendt T; Kientsch-Engel R; Stahl P; Fengler D; Kuhla B
    Neurobiol Aging; 2005 Apr; 26(4):465-74. PubMed ID: 15653175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins.
    Zeng J; Davies MJ
    Chem Res Toxicol; 2005 Aug; 18(8):1232-41. PubMed ID: 16097796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
    Ansari NA; Moinuddin ; Alam K; Ali A
    Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid-phase synthesis of glucose-derived Amadori peptides.
    Frolov A; Singer D; Hoffmann R
    J Pept Sci; 2007 Dec; 13(12):862-7. PubMed ID: 17883244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of flavour compounds in the Maillard reaction.
    van Boekel MA
    Biotechnol Adv; 2006; 24(2):230-3. PubMed ID: 16386869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maillard glycation of beta-lactoglobulin induces conformation changes.
    Chevalier F; Chobert JM; Dalgalarrondo M; Choiset Y; Haertlé T
    Nahrung; 2002 Apr; 46(2):58-63. PubMed ID: 12017991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural studies of the Maillard reaction products of a protein using ion trap mass spectrometry.
    Tagami U; Akashi S; Mizukoshi T; Suzuki E; Hirayama K
    J Mass Spectrom; 2000 Feb; 35(2):131-8. PubMed ID: 10679972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycosylation of lysine-containing pentapeptides by glucuronic acid: new insights into the Maillard reaction.
    Horvat S; Roscić M
    Carbohydr Res; 2010 Feb; 345(3):377-84. PubMed ID: 20034621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.
    Schalkwijk CG; Stehouwer CD; van Hinsbergh VW
    Diabetes Metab Res Rev; 2004; 20(5):369-82. PubMed ID: 15343583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The maillard reaction in eye diseases.
    Stitt AW
    Ann N Y Acad Sci; 2005 Jun; 1043():582-97. PubMed ID: 16037281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced glycation endproducts and cigarette smoking.
    Nicholl ID; Bucala R
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1025-33. PubMed ID: 9846884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycation of lysine-containing dipeptides.
    Mennella C; Visciano M; Napolitano A; Del Castillo MD; Fogliano V
    J Pept Sci; 2006 Apr; 12(4):291-6. PubMed ID: 16180244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
    Nawale RB; Mourya VK; Bhise SB
    Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.